I provide strategic scientific and technical support to biotechnology companies, from early platform development and candidate selection through preclinical development and clinical-stage programmes. Engagements can address a specific challenge or provide ongoing senior scientific leadership.

Fractional Executive Leadership

Experienced scientific leadership without the need for a full-time executive appointment.

I work with founders, management teams and boards to provide senior scientific input, shape R&D strategy and help companies make critical development decisions. Support can range from regular advisory input to an embedded fractional CSO or CTO role.

Fractional CSO • R&D Strategy • Board Advisory

Platform & Pipeline Strategy

Building strong technology platforms and translating them into focused, differentiated pipelines.

I help companies assess the strengths and limitations of their technology, identify the most appropriate applications and indications, and establish clear criteria for programme selection and progression.

Technology Assessment • Portfolio Strategy • Target Product Profiles

Programme & Translational Strategy

Turning promising science into a coherent development programme.

This includes defining the key scientific questions, selecting appropriate preclinical models and biomarkers, identifying evidence gaps and establishing the studies and decision points needed to progress towards clinical development.

Preclinical Strategy • Biomarkers • Candidate Selection

RNA Therapeutics & Advanced Modalities

Specialist support for companies developing RNA therapeutics and other innovative therapeutic approaches.

My experience spans mRNA therapeutics, RNA design, lipid nanoparticles and alternative delivery technologies, as well as broader experience across small molecules, biologics and microbiome therapeutics. I support both platform development and individual therapeutic programmes.

RNA Therapeutics • Drug Delivery • Platform Development

Externalised R&D

Making external development an effective extension of the internal team.

I support the identification and selection of CROs, CDMOs and specialist partners, evaluation of proposals and capabilities, and scientific oversight of outsourced work. The focus is on ensuring that external activities answer the right questions and remain aligned with the overall development strategy.

CRO/CDMO Oversight • Vendor Selection • Technical Governance

Scientific & Technical Due Diligence

Independent scientific assessment to support important business decisions.

I evaluate technologies, therapeutic programmes and development plans for biotechnology companies, investors and other stakeholders, identifying scientific strengths, development risks, critical gaps and areas requiring further investigation.

Technology Review • Risk Assessment • Investment Support